TGM2 and ovarian carcinoma: Transforming growth factor (TGF)-β mediates epithelial mesenchymal transition (EMT) in ovarian cancer by regulating tissue transglutaminase (TG2) involved in cell proliferation, differentiation and apoptosis, and is associated with the development of CSCs.